WallStreetZenWallStreetZen

NYSE: DOCS
Doximity Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DOCS past earnings growth

How has DOCS's earnings growth performed historically?
Company
14.29%
Industry
-4.25%
Market
71.87%
DOCS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DOCS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DOCS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DOCS past revenue growth

How has DOCS's revenue growth performed historically?
Company
16.58%
Industry
11.98%
Market
17.2%
DOCS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DOCS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DOCS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DOCS earnings and revenue history

Current Revenue
$468.3M
Current Earnings
$137.6M
Current Profit Margin
29.4%

DOCS Return on Equity

Current Company
14.9%
Current Industry
-0.2%
Current Market
188%
DOCS's Return on Equity (14.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DOCS announces earnings.

DOCS Return on Assets

Current Company
12.8%
Current Industry
0.8%
DOCS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DOCS Return on Capital Employed

Current Company
19.42%
Current Industry
2.2%

DOCS vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DOCS$468.33M$186.53M$137.63M+21.63%-2.02%
RCM$2.25B$437.70M$3.30M+21.02%-99.16%
EVH$1.96B-$24.79M-$142.26M+25.65%N/A
TXG$618.73M-$205.11M-$255.10M+33.43%N/A
PGNY$1.09B$69.67M$62.04M+59.52%+74.65%
View Top Health Information Service Stocks

DOCS earnings dates

Next earnings date
May 16, 2024

Doximity Earnings & Revenue FAQ

What were DOCS's earnings last quarter?

On Invalid Date, Doximity (NYSE: DOCS) reported Q4 2023 earnings per share (EPS) of $0.26, up 52.94% year over year. Total Doximity earnings for the quarter were $47.96 million. In the same quarter last year, Doximity's earnings per share (EPS) was $0.17.

If you're new to stock investing, here's how to buy Doximity stock.

What was DOCS's earnings growth in the past year?

As of Q2 2024, Doximity's earnings has grown 14.29% year over year. This is 18.54 percentage points higher than the US Health Information Services industry earnings growth rate of -4.25%. Doximity's earnings in the past year totalled $137.63 million.

What is DOCS's earnings date?

Doximity's earnings date is Invalid Date. Add DOCS to your watchlist to be reminded of DOCS's next earnings announcement.

What was DOCS's revenue last quarter?

On Invalid Date, Doximity (NYSE: DOCS) reported Q4 2023 revenue of $135.28 million up 17.37% year over year. In the same quarter last year, Doximity's revenue was $115.26 million.

What was DOCS's revenue growth in the past year?

As of Q2 2024, Doximity's revenue has grown 16.58% year over year. This is 4.6 percentage points higher than the US Health Information Services industry revenue growth rate of 11.98%. Doximity's revenue in the past year totalled $468.33 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.